A systematic review and network meta-analysis protocol of neoadjuvant treatments for patients with gastric cancer.

about

A systematic review and network meta-analysis protocol of neoadjuvant treatments for patients with gastric cancer.

Item

http://www.wikidata.org/entity/Q52593832

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A systematic review and networ ...... patients with gastric cancer.

@en

A systematic review and networ ...... patients with gastric cancer.

@nl

type

Item

label

A systematic review and networ ...... patients with gastric cancer.

@en

A systematic review and networ ...... patients with gastric cancer.

@nl

prefLabel

A systematic review and networ ...... patients with gastric cancer.

@en

A systematic review and networ ...... patients with gastric cancer.

@nl

P1476

A systematic review and networ ...... patients with gastric cancer.

@en

P2093

Bo Long

http://www.w3.org/2001/XMLSchema#string

Hao Zhan

http://www.w3.org/2001/XMLSchema#string

Heng-Rui Du

http://www.w3.org/2001/XMLSchema#string

Qiong Li

http://www.w3.org/2001/XMLSchema#string

Ze-Yuan Yu

http://www.w3.org/2001/XMLSchema#string

Zhen-Jiang Wang

http://www.w3.org/2001/XMLSchema#string

Zuo-Yi Jiao

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Quantifying heterogeneity in a meta-analysis

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Cancer statistics, 2013

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.

Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.

Neo-adjuvant and adjuvant chemotherapy of gastric cancer.

P304

e0392

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1097/MD.0000000000010392

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29642200

http://www.w3.org/2001/XMLSchema#string

P932

5908618

http://www.w3.org/2001/XMLSchema#string